QEHSQEHS

Customers / Pharma

Deviation + change-control cycle time halved under 21 CFR Part 11.

A mid-size contract manufacturer replaced a legacy eQMS with a Composer-built quality system — 21 CFR Part 11 compliant.

PharmaQualityDeviationChange control21 CFR Part 11Batch record review

-52%

Deviation cycle time

10d

FDA audit prep

0

Part 11 findings

Situation

Validation packets were manual. Deviations sat in email threads. Change control bypassed QA regularly. FDA warning-letter risk was elevated.

Approach

  • Composer modules for deviation, change control, and investigation
  • E-sign with step-up MFA on regulated transitions (W3C VC)
  • ALCOA+ audit trail with hash-chained record history
  • Validation packets generated via report engine per batch

Outcomes

  • Deviation cycle time cut 52%
  • FDA audit prep reduced from 6 weeks to 10 days
  • Zero Part 11 findings on the following audit

Hash-chained audit + step-up MFA + ALCOA+ — we ticked every box FDA asked about. The validation packet regenerates on demand, per batch, without an export marathon.

VP Quality, Silverleaf Pharma (pseudonym)

Identifying details anonymised pending reference agreement. Metrics reported by deployment team.

Your program could be here

Stand up your first QEHS module in weeks, not quarters.

Design partner slots still open — early pricing, dedicated implementation, and reference-story co-creation.